Spyre Therapeutics SYRE
Last Price
52 Week Range
$10.91 - $35.31
Next Earnings Date
Feb 26 2026 (Estimate)
Next Earnings Date
Feb 26 2026 (Est.)
Last Price
SYRE Filings
Company Name | Form Type | Filed | View |
|---|---|---|---|
Spyre Therapeutics, Inc. | 10-Q | November 4, 2025 | |
Spyre Therapeutics, Inc. | 8-K | November 4, 2025 | |
Spyre Therapeutics, Inc. | 8-K | October 15, 2025 | |
Spyre Therapeutics, Inc. | 8-K | October 14, 2025 | |
Spyre Therapeutics, Inc. | 10-Q | August 5, 2025 | |
Spyre Therapeutics, Inc. | 8-K | August 5, 2025 | |
Spyre Therapeutics, Inc. | 8-K | June 17, 2025 | |
Spyre Therapeutics, Inc. | 8-K | June 2, 2025 | |
Spyre Therapeutics, Inc. | 10-Q | May 8, 2025 | |
Spyre Therapeutics, Inc. | 8-K | May 8, 2025 | |
Spyre Therapeutics, Inc. | ARS | April 14, 2025 | |
Spyre Therapeutics, Inc. | DEF 14A | April 14, 2025 | |
Spyre Therapeutics, Inc. | DEFA14A | April 14, 2025 | |
Spyre Therapeutics, Inc. | 8-K | March 6, 2025 | |
Spyre Therapeutics, Inc. | 8-K | February 27, 2025 | |
Spyre Therapeutics, Inc. | 10-K | February 27, 2025 | |
Spyre Therapeutics, Inc. | 8-K | January 13, 2025 | |
Spyre Therapeutics, Inc. | 8-K | November 19, 2024 | |
Spyre Therapeutics, Inc. | 8-K | November 18, 2024 | |
Spyre Therapeutics, Inc. | 8-K | November 12, 2024 | |
Spyre Therapeutics, Inc. | 10-Q | November 7, 2024 | |
Spyre Therapeutics, Inc. | 8-K | November 7, 2024 | |
Spyre Therapeutics, Inc. | 8-K | October 15, 2024 | |
Spyre Therapeutics, Inc. | 10-Q | August 7, 2024 | |
Spyre Therapeutics, Inc. | 8-K | August 7, 2024 | |
Spyre Therapeutics, Inc. | 8-K | May 30, 2024 | |
Spyre Therapeutics, Inc. | 8-K | May 15, 2024 | |
Spyre Therapeutics, Inc. | 10-Q | May 9, 2024 | |
Spyre Therapeutics, Inc. | 8-K | May 9, 2024 | |
Spyre Therapeutics, Inc. | 8-K | April 25, 2024 |
NEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersNEWSLETTER
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data ProvidersGainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.